Evaluation of influenza-specific humoral response by microbead array analysis

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Accurate measurement of immune responses to influenza vaccination is crucial for developing effective vaccines.
• Traditional methods for quantifying antigen-specific antibodies are often expensive, time-consuming, and require large sample volumes.
• Suspension microbead array (MBA) technology offers a multiplexed, cost-effective, and sample-sparing alternative for immune response analysis.

Purpose of the Study:

• To demonstrate the utility of MBA technology for comparing influenza-specific humoral immune responses.
• To compare the antibody profiles of two distinct populations with varying influenza strains and vaccination rates.

Main Methods:

• Influenza hemagglutinin (HA) antigens from various strains were immobilized on microbeads.
• Serum samples from Winnipeg (Canada) and Kenyan donors were incubated with the antigen-coated microbeads.
• Immunoglobulin (Ig) A1 and IgG1 antibody levels specific to influenza HA were quantified using MBA.

Main Results:

• Significant differences in IgA1 and IgG1 antibody responses to specific influenza strains were observed between the Winnipeg and Kenyan cohorts.
• Winnipeg donors exhibited higher mean fluorescence intensity values for several anti-HA IgA1 and IgG1 antibodies compared to Kenyan donors.
• No significant differences were found in the antibody response to the B/Jilin/20/2003 strain between the two groups.

Conclusions:

• MBA technology successfully detected and quantified influenza-specific IgA1 and IgG1 antibodies.
• A notable difference in antibody response profiles was identified between serum samples from Winnipeg and Kenyan donors.
• MBA analysis presents a rapid, cost-effective, and highly multiplexed approach for monitoring vaccine-induced immune responses.